Skip to search formSkip to main contentSkip to account menu

iosmin

Known as: N,N'-bis(3-carbamoyl-5-(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl)-N,N'-bis(2,3-dihydroxypropyl)malonamide, iosimenol 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

BenzamidesPropanolamines

Narrower (1)

ICJ 3393

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Effects of viscosity on power and hand injection of iso-osmolar iodinated contrast media through thin catheters
Background It can be challenging to achieve adequate vessel opacification during percutaneous coronary interventions when using… 
2015
2015
The pharmacokinetic profile, tolerability and safety of the iodinated, non-ionic, dimeric contrast medium Iosimenol 340 injection in healthy human subjects
Background Iosimenol 340 injection is a new isotonic iodinated contrast medium for X-ray angiography. Purpose To investigate the… 
2015
2015
Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience
Background Iosimenol 340 injection is a new, dimeric, iso-osmolar, iodinated contrast medium for X-ray angiography. Purpose To… 
2013
2013
Electrocardiographic response to intravenous and intraarterial injection of iosimenol (a new, iodinated, non-ionic, iso-osmolar contrast medium).
Serious arrhythmias, sometimes related to the injection of iodinated contrast media, are known complications of cardiac… 
2009
2009
In-vitro Studie zur Wirksamkeit der Kombination von Antibiotika und Roentgen-Kontrastmitteln bei der Diskographie
Ziele: Die Diskographie wurde wegen des Risikos der iatrogenen Diszitis stets kontrovers diskutiert; durch technische… 
2007
2007
Iosimenol, a new non-ionic dimeric contrast medium, does not induce immunoreactivity in the popliteal lymph node assay.
Animal studies in mice were conducted to determine the potential immunoreactivity of the new non-ionic dimeric contrast medium… 
2007
2007
CMR 2007: 10.02: A randomized comparison of safety, tolerance and contrast of intravenous iosimenol with iodixanol (Visipaque®) in patients undergoing whole-body computed tomography
2004
2004
Iosimenol, a Low-Viscosity Nonionic Dimer: Preclinical Physicochemistry, Pharmacology, and Pharmacokinetics
Rationale and Objectives:Newer radiologic techniques require fast bolus injections and thus low-viscosity, high-concentration… 
2003
2003
No Difference Among Modern Contrast Media's Effect on Neointimal Proliferation and Restenosis After Coronary Stenting in Pigs
Rationale and Objectives:Recent clinical trials indicate that the choice of radiographic contrast media (CM) may influence the… 
2002
2002
Acute Cardiac Tolerance of Current Contrast Media and the New Taxane Protaxel Using Iopromide as Carrier During Porcine Coronary Angiography and Stenting
Scheller B, Speck U, Schmitt A, et al. Acute cardiac tolerance of current contrast media and the new taxane protaxel using… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)